NUMIF (Numinus Wellness) Return-on-Tangible-Equity: 0.00% (As of May. 2025)


What is Numinus Wellness Return-on-Tangible-Equity?

Numinus Wellness NUMIF -25.77% Return-on-Tangible-Equity is 0.00% as of May. 2025. Among 581 Healthcare Providers & Services companies, Numinus Wellness ranks worse than 99.83% on this metric.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Numinus Wellness's annualized net income for the quarter that ended in May. 2025 was $-2.05 Mil. Numinus Wellness's average shareholder tangible equity for the quarter that ended in May. 2025 was $-0.85 Mil. Therefore, Numinus Wellness's annualized Return-on-Tangible-Equity for the quarter that ended in May. 2025 was N/A%.

The historical rank and industry rank for Numinus Wellness's Return-on-Tangible-Equity or its related term are showing as below:

NUMIF's Return-on-Tangible-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 9.93
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Numinus Wellness  (OTCPK:NUMIF) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Numinus Wellness Return-on-Tangible-Equity Related Terms


Numinus Wellness Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for Numinus Wellness's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Numinus Wellness Return-on-Tangible-Equity Chart

Numinus Wellness Annual Data
Trend Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Return-on-Tangible-Equity
Get a 7-Day Free Trial -461.41 -59.13 -88.82 -111.17 -262.62

Numinus Wellness Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -310.23 -527.14 -4,273.29 0.00 0.00

NUMIF vs HLYK, SYRA, GBCS: Return-on-Tangible-Equity Comparison

For the Medical Care Facilities subindustry, Numinus Wellness's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Numinus Wellness Return-on-Tangible-Equity vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Numinus Wellness's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Numinus Wellness's Return-on-Tangible-Equity falls into.



Numinus Wellness Return-on-Tangible-Equity Calculation

Numinus Wellness's annualized Return-on-Tangible-Equity for the fiscal year that ended in Aug. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Aug. 2024 )  (A: Aug. 2023 )(A: Aug. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Aug. 2024 )  (A: Aug. 2023 )(A: Aug. 2024 )
=-14.385/( (10.424+0.531 )/ 2 )
=-14.385/5.4775
=-262.62 %

Numinus Wellness's annualized Return-on-Tangible-Equity for the quarter that ended in May. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: May. 2025 )  (Q: Feb. 2025 )(Q: May. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: May. 2025 )  (Q: Feb. 2025 )(Q: May. 2025 )
=-2.052/( (-0.571+-1.121)/ 2 )
=-2.052/-0.846
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (May. 2025) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of 0.00% mean?
Numinus Wellness (NUMIF) has a Return-on-Tangible-Equity of 0.00% as of May. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Numinus Wellness and its competitors. According to the industry distribution chart, Numinus Wellness ranks #580 out of 581 companies in the Healthcare Providers & Services industry, placing it in the top 99.8%.
Is Numinus Wellness' Return-on-Tangible-Equity too high?
Numinus Wellness' current Return-on-Tangible-Equity is 0.00%. Based on the distribution chart, Numinus Wellness ranks #580 out of 581 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Numinus Wellness' Return-on-Tangible-Equity compare to HLYK and SYRA?
According to the Healthcare Providers & Services industry distribution chart, Numinus Wellness ranks #580 out of 581 companies for Return-on-Tangible-Equity. This places Numinus Wellness in the lower half of its industry. The industry median Return-on-Tangible-Equity is 9.93. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 9.93, based on 581 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Numinus Wellness and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 9.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Numinus Wellness's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numinus Wellness stock overvalued right now?
Numinus Wellness (NUMIF) has a current Return-on-Tangible-Equity of 0.00%. The current Return-on-Tangible-Equity is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Numinus Wellness (NUMIF), the current Return-on-Tangible-Equity is 0.00% as of May. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Numinus Wellness Business Description

Address 801 - 33 Water Street, Vancouver, BC, CAN, V6B 1R4
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.